लोड हो रहा है...
A rare case of synchronous multiple primary lung cancer with different responses to gefitinib
Differentiating multiple primary lung cancer (MPLC) from lung metastasis is important, and the pathology and gene mutations may be different between the tumors. A lung biopsy to differentiate lesions should be considered, especially when the response of different tumors to treatment is distinct.
में बचाया:
| में प्रकाशित: | Respir Med Case Rep |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Elsevier
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7596341/ https://ncbi.nlm.nih.gov/pubmed/33145160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101270 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|